Universal admission testing with a rapid molecular point-of-care test and real-time polymerase chain reaction (PCR) assay for the detection of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Comparative performance and infection prevention implications

Infect Control Hosp Epidemiol. 2023 Jan;44(1):138-140. doi: 10.1017/ice.2022.244. Epub 2022 Oct 18.

Authors

Alfredo J Mena Lora^{1

2}, Lelia H Chaisson¹, Eric Wenzler¹, Scott Borgetti¹, Susan C Bleasdale¹

Affiliations

¹ University of Illinois at Chicago, Chicago, Illinois.
² Saint Anthony Hospital, Chicago, Illinois.

PMID: 36254755
DOI: 10.1017/ice.2022.244

No abstract available

MeSH terms

COVID-19 Testing
COVID-19* / diagnosis
COVID-19* / prevention & control
Humans
Point-of-Care Testing
Real-Time Polymerase Chain Reaction
SARS-CoV-2 / genetics
Sensitivity and Specificity
Virus Diseases*